Neurofilament light chain as a biomarker for neurodegenerative changes in COVID-19 and clinical implications
Future Virology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 15
Published: March 21, 2025
Language: Английский
Cognitive reserve in young-onset cognitive impairment
Brain and Cognition,
Journal Year:
2025,
Volume and Issue:
186, P. 106297 - 106297
Published: April 11, 2025
Language: Английский
Altered amyloid plasma profile in patients with disabling headaches after SARS-CoV-2 infection and vaccination
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 22, 2024
Abstract
Background
and
objectives
New
onset
persistent
headache
has
been
reported
following
acute
COVID-19
to
some
degree
also
after
SARS-CoV-2
vaccination.
The
mechanisms
for
these
types
are
unclear.
purpose
of
this
study
was
assess
levels
amyloid
related
biomarkers
in
patients
with
vaccine.
Methods
In
prospective
observational
cohort,
severe
as
the
dominating
symptom
(n=29)
vaccination
(n=31),
had
neurological
assessments
reassessments
6
months.
Plasma
precursor
protein
(APP),
pregnancy
zone
(PZP),
cathepsin
L1
(CTSL)
serum
Amyloid
A
(SAA1)
were
measured
by
ELISA
relation
healthy
controls
(n=16).
Results
We
found
a
strong
upregulation
APP
compared
two
other
groups.
At
both
inclusion
months
increased
those
accompanying
cognitive
symptoms.
contrast,
plasma
PZP
elevated
at
controls.
CTSL
only
associated
vaccine
baseline,
whereas
SAA1
showed
comparable
all
Conclusion
Altered
soluble
markers
potentially
reflecting
changes
processing
particular
where
we
association
NCT04576351
NCT05235776
What
is
already
known
on
topic
occurs
subset
individuals
extent
However,
pathophysiological
unknown.
adds
that
could
reflect
How
might
affect
research,
practice
or
policy
Our
data
underscore
need
more
long-time
follow-up
new
include
blood
tests
neuroinflammation.
Language: Английский
Exposure to Cadmium and Other Trace Elements Among Individuals with Mild Cognitive Impairment
Toxics,
Journal Year:
2024,
Volume and Issue:
12(12), P. 933 - 933
Published: Dec. 22, 2024
Background:
A
limited
number
of
studies
have
investigated
the
role
environmental
chemicals
in
etiology
mild
cognitive
impairment
(MCI).
We
performed
a
cross-sectional
study
association
between
exposure
to
selected
trace
elements
and
biomarkers
decline.
Methods:
During
2019–2021,
we
recruited
128
newly
diagnosed
patients
with
MCI
from
two
Neurology
Clinics
Northern
Italy,
i.e.,
Modena
Reggio
Emilia.
At
baseline,
measured
serum
cerebrospinal
fluid
(CSF)
concentrations
cadmium,
copper,
iron,
manganese,
zinc
using
inductively
coupled
plasma
mass
spectrometry.
With
immuno-enzymatic
assays,
estimated
β-amyloid
1-40,
1-42,
Total
Tau
phosphorylated
Tau181
proteins,
neurofilament
light
chain
(NfL),
mini-mental
state
examination
(MMSE)
assess
status.
used
spline
regression
explore
shape
each
endpoint,
adjusted
for
age
at
diagnosis,
educational
attainment,
MMSE,
sex.
Results:
In
analyses
CSF
metals,
found
monotonic
positive
correlations
copper
zinc,
while
an
inverse
was
observed
cadmium.
Serum
cadmium
were
inversely
associated
amyloid
ratio
positively
proteins.
iron
showed
opposite
trend,
displayed
heterogeneous
non-linear
associations
biomarkers.
Regarding
biomarkers,
only
consistently
ratio,
Tau.
Cadmium
not
appreciably
NfL
levels,
inverted
U-shaped
NfL,
similar
that
copper.
CSF,
element
high
concentrations.
Conclusions:
this
study,
impairment.
Findings
other
difficult
interpret,
showing
complex
inconsistent
neurodegenerative
endpoints
examined.
Language: Английский